Generics

Originals

Biosimilars

Medical devices

Nutraceuticals 1

Filters

Silymarin manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Indonesia

Clear all

1 products found

silymarin + schizandrae + vitamin b12 + vitamin b6 + vitamin e

Capsules

Country of origin
Indonesia
GMP approvals
Indonesia
Recommended use
Liver support
Product description
Lecithin, Curcuma, Nicotinamide. Helpsmaintain healthyliver.
Unavailable markets
Philippines
Manufacturer #559

Manufacturer usually replies in 8 days

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Silymarin is an extract of milk thistle seeds that has antioxidant properties and is primarily used in supplement formulations to treat liver conditions. Suppliers of silymarin market it in the forms of oral capsules, tablets, powders, as well as liquid extracts. Silymarin suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified silymarin manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. Retail prices per 30 tablets of silymarin vary approximately from 4,00 EUR to 17,00 EUR.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation